Skip to main content
RUBICON RESEARCH LIMITED logo

RUBICON RESEARCH LIMITED — Investor Relations & Filings

Ticker · RUBICON ISIN · INE506V01022 LEI · 335800GME6PCQIKP8T34 BSE.NS Manufacturing
Open in API
Filings indexed 116 across all filing types
Latest filing 2026-01-27 Regulatory Filings
Country IN India
Listing BSE.NS RUBICON

About RUBICON RESEARCH LIMITED

https://www.rubicon.co.in/

Rubicon Research Limited is a specialty organization focused on formulation development and the commercialization of value-added products. The company leverages proprietary drug delivery technology platforms to develop complex oral solids, liquids, topicals, and sterile dosage forms. Its core business activities encompass contract research and manufacturing services alongside the development of a diverse portfolio of Abbreviated New Drug Applications. The firm operates advanced research and development centers and manufacturing facilities that comply with stringent international regulatory standards. Rubicon Research emphasizes innovation in life cycle management and the enhancement of existing molecules to improve patient compliance and therapeutic outcomes. Its operations provide end-to-end solutions from initial concept and formulation design to commercial-scale production, serving global markets with a focus on high-quality, technology-driven solutions.

Recent filings

Filing Released Lang Actions
Rubicon Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve The Unaudited Standalone And ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about a scheduled Board Meeting to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document does not contain the financial results themselves but is an intimation or notice about the upcoming board meeting where such results will be approved. The document length is 2636 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this is an announcement of a board meeting and financial results approval, not the financial report itself. This fits best under Regulatory Filings (RNS) as a general regulatory announcement about an upcoming event and disclosure obligation.
2026-01-27 English
Disclosure of material issue
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the incorporation of a wholly owned subsidiary, 'AdvaGen S A Company', in Saudi Arabia. The document includes details such as the date of incorporation, shareholding, and nature of consideration. There are no financial statements, earnings data, or detailed management analysis. The document is a regulatory announcement about a corporate event (subsidiary incorporation) rather than a financial report or detailed presentation. It fits the category of a regulatory announcement under SEBI regulations, which is best classified as a Regulatory Filing (RNS). The document length is 4462 characters, which is short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-01-14 English
Incorporation of a Wholly Owned Subsidiary
Regulatory Filings Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the incorporation of a wholly owned subsidiary, 'AdvaGen S A Company', in Saudi Arabia. The document includes details such as the date of incorporation, shareholding, and nature of consideration. There are no financial statements, earnings data, or management discussion. The document is a regulatory announcement about a corporate event (subsidiary incorporation) and does not fit into financial reports or earnings releases. It is a typical example of a regulatory filing under SEBI regulations for material events. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 4462 characters, which is short and consistent with an announcement rather than a full report.
2026-01-14 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the appointment of a senior management personnel, Ms. Avani Harish Shah, as General Manager – Secretarial, Legal & Compliance. It references compliance with SEBI Listing Regulations and provides detailed information about the appointment, including the date and profile of the appointee. There is no financial data, earnings information, or report attached or referenced as being published. The content clearly fits the category of announcements related to changes in senior management. Therefore, the document is best classified under Board/Management Information (MANG). The document length is 5328 characters, which is sufficient for a detailed management change announcement.
2026-01-09 English
Rubicon Research Limited has informed to the Stock Exchange regarding Appointment of Senior Management Personnel.
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the appointment of a senior management personnel, Ms. Avani Harish Shah, as General Manager – Secretarial, Legal & Compliance. It references compliance with SEBI Listing Regulations and provides detailed information about the appointment, including the date and profile of the appointee. There is no financial data, earnings information, or report attached or referenced. The content clearly fits the category of announcements related to changes in senior management or board members. Therefore, the document is best classified as Board/Management Information (MANG). The document length is 5328 characters, which is sufficient for a detailed announcement but not a full report.
2026-01-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended December 31, 2025. It is a confirmation letter from the Registrar and Share Transfer Agent to the company and stock exchanges. The document does not contain financial statements or detailed financial analysis but is a regulatory compliance certificate. It is short (4233 characters) and serves as a compliance confirmation rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and confirmations.
2026-01-09 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.